Some medical conditions may exclude you from semaglutide treatment, even if you meet the BMI requirements
Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for chronic weight management, commonly affects bowel movements as part of its mechanism of action
Retained Gastric Contents Studies Multiple studies have consistently demonstrated increased rates of retained gastric contents in patients taking GLP-1 RAs, though with variable magnitude depending on study design and patient populations [32]
Skin is the first line of defence for your body, protecting you from the outside world
Quick Answer: Semaglutide-induced constipation is typically managed with increased hydration, dietary fiber (25-38g daily), regular physical activity, and first-line use of polyethylene glycol 3350 when conservative measures are insufficient
This means food stays in your stomach longer, which makes you feel full for a longer time